ArticleHealthcare (Basel, Switzerland)2023
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status.
Kiyoka Sawada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.